Alvotech (ALVO) Competitors $7.95 +0.11 (+1.45%) Closing price 03:58 PM EasternExtended Trading$7.94 -0.01 (-0.18%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALVO vs. QGEN, ROIV, RVMD, LNTH, BBIO, TGTX, LEGN, SRPT, TLX, and ADMAShould you be buying Alvotech stock or one of its competitors? The main competitors of Alvotech include Qiagen (QGEN), Roivant Sciences (ROIV), Revolution Medicines (RVMD), Lantheus (LNTH), BridgeBio Pharma (BBIO), TG Therapeutics (TGTX), Legend Biotech (LEGN), Sarepta Therapeutics (SRPT), Telix Pharmaceuticals Limited American Depositary Shares (TLX), and ADMA Biologics (ADMA). These companies are all part of the "pharmaceutical products" industry. Alvotech vs. Qiagen Roivant Sciences Revolution Medicines Lantheus BridgeBio Pharma TG Therapeutics Legend Biotech Sarepta Therapeutics Telix Pharmaceuticals Limited American Depositary Shares ADMA Biologics Qiagen (NYSE:QGEN) and Alvotech (NASDAQ:ALVO) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations. Which has more risk and volatility, QGEN or ALVO? Qiagen has a beta of 0.62, suggesting that its stock price is 38% less volatile than the S&P 500. Comparatively, Alvotech has a beta of -0.05, suggesting that its stock price is 105% less volatile than the S&P 500. Does the media prefer QGEN or ALVO? In the previous week, Qiagen had 10 more articles in the media than Alvotech. MarketBeat recorded 13 mentions for Qiagen and 3 mentions for Alvotech. Qiagen's average media sentiment score of 0.82 beat Alvotech's score of -0.09 indicating that Qiagen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Qiagen 8 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alvotech 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Is QGEN or ALVO more profitable? Qiagen has a net margin of 4.23% compared to Alvotech's net margin of -123.47%. Qiagen's return on equity of 13.92% beat Alvotech's return on equity.Company Net Margins Return on Equity Return on Assets Qiagen4.23% 13.92% 8.40% Alvotech -123.47%N/A -35.87% Do insiders and institutionals hold more shares of QGEN or ALVO? 70.0% of Qiagen shares are owned by institutional investors. 9.0% of Qiagen shares are owned by insiders. Comparatively, 0.5% of Alvotech shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts rate QGEN or ALVO? Qiagen presently has a consensus price target of $48.42, indicating a potential upside of 13.15%. Alvotech has a consensus price target of $18.00, indicating a potential upside of 129.59%. Given Alvotech's stronger consensus rating and higher possible upside, analysts clearly believe Alvotech is more favorable than Qiagen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Qiagen 0 Sell rating(s) 7 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.30Alvotech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings and valuation, QGEN or ALVO? Qiagen has higher revenue and earnings than Alvotech. Alvotech is trading at a lower price-to-earnings ratio than Qiagen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQiagen$1.98B4.81$83.59M$0.36118.86Alvotech$489.68M4.83-$551.73M-$0.87-9.01 Does the MarketBeat Community believe in QGEN or ALVO? Qiagen received 242 more outperform votes than Alvotech when rated by MarketBeat users. Likewise, 60.00% of users gave Qiagen an outperform vote while only 50.00% of users gave Alvotech an outperform vote. CompanyUnderperformOutperformQiagenOutperform Votes24960.00% Underperform Votes16640.00% AlvotechOutperform Votes750.00% Underperform Votes750.00% SummaryQiagen beats Alvotech on 15 of the 18 factors compared between the two stocks. Get Alvotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ALVO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALVO vs. The Competition Export to ExcelMetricAlvotechBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.37B$3.00B$5.56B$7.83BDividend YieldN/A1.89%5.11%4.22%P/E Ratio-4.2430.4222.4818.48Price / Sales4.83498.92394.56103.59Price / CashN/A168.6838.1834.62Price / BookN/A3.206.774.25Net Income-$551.73M-$72.35M$3.22B$248.23M7 Day Performance-6.33%1.46%1.48%0.89%1 Month Performance-18.67%8.79%3.99%3.53%1 Year Performance-45.86%-22.36%16.15%5.08% Alvotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALVOAlvotech1.7401 of 5 stars$7.95+1.5%$18.00+126.3%-45.9%$2.40B$489.68M-4.304Short Interest ↑QGENQiagen3.6936 of 5 stars$42.49+1.0%$47.83+12.6%+4.0%$9.45B$1.98B118.316,030Upcoming EarningsAnalyst RevisionROIVRoivant Sciences2.2052 of 5 stars$11.19+1.6%$17.50+56.4%+6.6%$7.98B$122.59M-74.60860Positive NewsRVMDRevolution Medicines3.766 of 5 stars$41.47+7.0%$66.67+60.8%+8.3%$7.71B$742,000.00-11.55250Upcoming EarningsAnalyst ForecastPositive NewsLNTHLantheus3.9766 of 5 stars$102.70+0.9%$129.43+26.0%+56.8%$7.03B$1.53B17.09700Upcoming EarningsNews CoveragePositive NewsBBIOBridgeBio Pharma4.5547 of 5 stars$35.89-1.2%$53.00+47.7%+49.7%$6.81B$221.90M-12.59400Earnings ReportAnalyst ForecastOptions VolumeNews CoverageTGTXTG Therapeutics3.3177 of 5 stars$42.03+1.7%$40.67-3.2%+233.2%$6.67B$329.00M-420.26290Upcoming EarningsNews CoveragePositive NewsLEGNLegend Biotech2.6407 of 5 stars$34.70+1.2%$78.82+127.1%-20.1%$6.37B$627.24M-36.531,070SRPTSarepta Therapeutics4.7356 of 5 stars$61.51+1.8%$158.70+158.0%-50.7%$5.97B$1.90B49.21840Upcoming EarningsTLXTelix Pharmaceuticals Limited American Depositary SharesN/A$17.57-6.5%$22.00+25.2%N/A$5.94B$783.21M0.00N/AAnalyst RevisionNews CoverageHigh Trading VolumeADMAADMA Biologics1.4608 of 5 stars$24.51+12.1%$22.50-8.2%+265.0%$5.82B$426.45M87.54530Upcoming EarningsOptions VolumeNews CoveragePositive NewsHigh Trading Volume Related Companies and Tools Related Companies QGEN Competitors ROIV Competitors RVMD Competitors LNTH Competitors BBIO Competitors TGTX Competitors LEGN Competitors SRPT Competitors TLX Competitors ADMA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALVO) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alvotech Please log in to your account or sign up in order to add this asset to your watchlist. Share Alvotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
